《新股消息》據報優然牧業進行上市聆訊 籌8億美元
市場消息指,內地優然牧業於本周進行聯交所上市聆訊,目標集資額高達8億美元。早前有傳優然牧業計劃集資約5億美元,並計劃透過上市前融資籌集約3億美元。
優然牧業已於去年11月提交上市申請,聯席保薦人為華泰及瑞信。公司前身為內地乳業龍頭伊利股份(600887.SH)旗下全資子公司,業務包括生產原料奶及向牧場提供反芻動物養殖產品與服務。
初步招股文件顯示,伊利股份上市前股份40%,內地私募基金PAG為公司大股東,持股約42.89%,PAG作為獨立另類投資管理人,不參與集團的日常運營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.